Radiation Emergency Medical Management (REMM) is produced by
•Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (HHS/ASPR)
•National Library of Medicine (NLM)
•National Cancer Institute (NCI)
•Centers for Disease Control and Prevention (CDC)
REMM provides
•Guidance for health care providers, primarily physicians, about clinical diagnosis and treatment of radiation injury during radiological and nuclear emergencies
•Just-in-time, evidence-based, usable information with sufficient background and context to make complex issues understandable to those without formal radiation medicine expertise
•Web-based information that is also downloadable in advance, so that it would be available during an event if the internet is not accessible
Mobile REMM has key selected pages from REMM online, including:
•Patient management algorithms for radiation exposure, contamination, and more...
•Dose estimator for radiation exposure
•Adult and pediatric triage
•Isotopes of interest
•Radiation countermeasures
•Emergency contacts
New for this Version:
- New information from the FDA about countermeasure newly approved for radiation-induced myelosuppression
辐射紧急情况医疗管理（联美）是由生产
•健康和人类服务部，助理部长准备的办公室和响应部（HHS / ASPR）
•国立医学图书馆（NLM）
•国立癌症研究所（NCI）
•美国疾病控制和预防中心（CDC）
联美提供
•在放射性和核紧急情况指导医疗机构，主要医师，有关临床诊断和治疗辐射伤害
•刚刚在时间，以证据为基础，可用有足够的背景和上下文信息，使理解那些复杂的问题，没有正式的放射医学专业知识
•基于Web的信息，它也可下载提前，因此，这将在事件期间可用如果互联网是不可访问
联美手机已经从联美键选定的页面在线，其中包括：
•病人管理算法的辐射，污染，以及更多...
•剂量估算辐射曝光
•成人和小儿分流
•利益同位素
•辐射对策
•紧急情况联系人
新的这个版本：
- 从FDA新的有关对策新批辐射引起的骨髓抑制
Mobile REMM更新内容
Version 2.0.3 has updated myeloid cytokines information based on FDA approval of second countermeasure for the indication of acute exposure to myelosuppressive doses of radiation. There are now 2 drugs that are FDA approved for this indication: Neupogen and Neulasta.
Version 2.0.4.1 fixed minor bugs. If you run into problem please upgrade your Android version to 5.1.
网友评论更多